Editorial comment: Statin/ezetimibe combination therapy: Emerging evidence

Current Opinion in Lipidology

Volumn 22, Issue 2, 2011, Pages 146-147

  Kalhan, Atul ^a   Rees, Alan ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; EZETIMIBE PLUS SIMVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PLACEBO; SIMVASTATIN; AZETIDINE DERIVATIVE; EZETIMIBE, SIMVASTATIN DRUG COMBINATION; HYPOCHOLESTEROLEMIC AGENT;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; EDITORIAL; HUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME; DRUG COMBINATION;

ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; AZETIDINES; DRUG COMBINATIONS; HUMANS; SIMVASTATIN;

EID: 79953738696     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283447835     Document Type: Editorial

References (7)

1. Garcia-Calvo M, Lisnock J, Bull HG, et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 2005; 102:8132-8137. (Pubitemid 40800055)
2. Kastelein J, Akdim F, Stroes E, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358:1431-1443. (Pubitemid 351482735)
3. Villines T, Stanek E, Devine P, et al. The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration. J Am Coll Cardiol 2010; 55:2721-2726.
4. Baigent C, Landray M, Collins R, et al. The Study of Heart and Renal Protection (SHARP) results. In: Proceedings of the American Society of Nephrology; 10 November 2010; Denver, Colorado.
5. Baigent C, Blackwell L, Emberson J, et al., Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet 2010; 376:1670-1681.
6. Armitage J, Bowman L, Wallendszus K, et al., Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group. Intensive lowering of LDL cholesterol with 80mg versus 20mg simvastatin daily in 12 064 survivors of myocardial infarction: a doubleblind randomised trial. Lancet 2010; 376:1658-1669.
7. Rossebo A, Pedersen T, Boman K, et al., Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Eng J Med 2008; 359:1343-1356.